These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3716786)
1. Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma. Pettersson B; Adami HO; Persson I; Bergström R; Lindgren A; Johansson ED Acta Obstet Gynecol Scand; 1986; 65(1):81-7. PubMed ID: 3716786 [TBL] [Abstract][Full Text] [Related]
2. The menopause: benefits and risks of estrogen-progestogen replacement therapy. Gambrell RD Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116 [TBL] [Abstract][Full Text] [Related]
3. [Estrogen treatment only when symptoms are present but complaints should not be neglected]. Widholm O Nord Med; 1977 May; 92(5):153. PubMed ID: 866107 [TBL] [Abstract][Full Text] [Related]
4. [Estrogen therapy and carcinoma of the endometrium (author's transl)]. Völker W; Kannengiesser U; Majewski A; Vasterling HW Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085 [TBL] [Abstract][Full Text] [Related]
6. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. Spengler RF; Clarke EA; Woolever CA; Newman AM; Osborn RW Am J Epidemiol; 1981 Oct; 114(4):497-506. PubMed ID: 7304580 [TBL] [Abstract][Full Text] [Related]
7. The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Persson IR; Adami HO; Eklund G; Johansson ED; Lindberg BS; Lindgren A Acta Obstet Gynecol Scand; 1986; 65(3):211-7. PubMed ID: 3739627 [TBL] [Abstract][Full Text] [Related]
13. [From the Adverse Drug Reaction Committee. Can long-term estrogen treatment induce uterine neoplasms in post-climacteric women?]. Setekleiv J; Borchgrevink CF Tidsskr Nor Laegeforen; 1976 Mar; 96(9-10):594-5. PubMed ID: 1258036 [TBL] [Abstract][Full Text] [Related]
14. [Hormone treatment in estrogen deficiency can be as natural as insulin in diabetes]. Furuhjelm M Nord Med; 1977 May; 92(5):154-5. PubMed ID: 866108 [TBL] [Abstract][Full Text] [Related]
15. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician. Berger GS; Fowler WC J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690 [TBL] [Abstract][Full Text] [Related]
16. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516 [TBL] [Abstract][Full Text] [Related]
17. [Recommendations for estrogen and progesterone replacement in climacteric and postmenopause. 33. Workshop of the "Zurich Discussion Circle", October 2004]. Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):53-7. PubMed ID: 16452821 [No Abstract] [Full Text] [Related]
18. Current status of estrogen replacement therapy. May WJ Am Fam Physician; 1977 Dec; 16(6):109-13. PubMed ID: 930801 [No Abstract] [Full Text] [Related]
19. The benefits of estrogen to the menopausal woman outweigh the risks of developing endometrial cancer. Braustein GD CA Cancer J Clin; 1984; 34(4):210-9. PubMed ID: 6430481 [No Abstract] [Full Text] [Related]
20. Estrogen replacement therapy and endometrial cancer: the elusive link. Maggio M J Nurse Midwifery; 1980; 25(2):19-21. PubMed ID: 6898648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]